## Abstract Criticalโsize bone defects usually require the insertion of autogenous bone graft to heal. Harvesting of bone is traumatic and results in high morbidity at the donor site. A potential alternative to bone graft may be a bone substitute with adequate biocompatibility and biological proper
In vivo biocompatibility and vascularization of biodegradable porous polyurethane scaffolds for tissue engineering
โ Scribed by M.W. Laschke; A. Strohe; C. Scheuer; D. Eglin; S. Verrier; M. Alini; T. Pohlemann; M.D. Menger
- Publisher
- Elsevier Science
- Year
- 2009
- Tongue
- English
- Weight
- 856 KB
- Volume
- 5
- Category
- Article
- ISSN
- 1742-7061
No coin nor oath required. For personal study only.
โฆ Synopsis
Scaffolds for tissue engineering should be biocompatible and stimulate rapid blood vessel ingrowth. Herein, we analyzed in vivo the biocompatibility and vascularization of three novel types of biodegradable porous polyurethane scaffolds. The polyurethane scaffolds, i.e., PU-S, PU-M and PU-F, were implanted into dorsal skinfold chambers of BALB/c mice. Using intravital fluorescence microscopy we analyzed vascularization of the implants and venular leukocyte-endothelial cell interaction in the surrounding host tissue over a 14 day period. Incorporation of the scaffolds was analyzed by histology, and a WST-1 assay was performed to evaluate their cell biocompatibility in vitro. Our results indicate that none of the polyurethane scaffolds was cytotoxic. Accordingly, rolling and adherent leukocytes in venules of the dorsal skinfold chamber were found in a physiological range after scaffold implantation and did not significantly differ between the groups, indicating a good in vivo biocompatibility. However, the three scaffolds induced a weak angiogenic response with a microvessel density of only approximately 47-60 and approximately 3-10cm/cm(2) in the border and centre zones of the scaffolds at day 14 after implantation. Histology demonstrated that the scaffolds were incorporated in a granulation tissue, which exhibited only a few blood vessels and inflammatory cells. In conclusion, PU-S, PU-M and PU-F scaffolds may be used to generate tissue constructs which do not induce a strong inflammatory reaction after implantation into patients. However, the scaffolds should be further modified or conditioned in order to accelerate and improve the process of vascularization.
๐ SIMILAR VOLUMES
## Abstract __In vivo__ tissue engineering uses the body as a bioreactor for tissue regeneration, thus placing stringent requirements on tissue scaffolds, which should be mechanically robust for immediate implantation without a long __in vitro__ cell culture time. In addition to mechanical strength
## Abstract The objective of this study was to determine how the incorporation of surfaceโmodified alumoxane nanoparticles into a biodegradable fumarateโbased polymer affects __in vivo__ bone biocompatibility (characterized by direct bone contact and bone ingrowth) and __in vivo__ degradability. Po
## Abstract The purpose of this research was to develop and characterize a novel, slowly degrading polyesterurethane. In this study, a polyesterurethane with a crystalline segment of poly((R)โ3โhydroxybutyric acid)โdiol linked by a diisocyanate to an amorphous segment of poly(ฮตโcaprolactoneโ__co__โ